Published in Cardiovasc Toxicol on December 01, 2012
Refractory spasm of coronary arteries and grafted conduits after isolated coronary artery bypass surgery. Ann Thorac Surg (2011) 2.93
Very long-term results (up to 17 years) with the double-orifice mitral valve repair combined with ring annuloplasty for degenerative mitral regurgitation. J Thorac Cardiovasc Surg (2012) 2.68
Neurologic Injury in Adults Supported With Veno-Venous Extracorporeal Membrane Oxygenation for Respiratory Failure: Findings From the Extracorporeal Life Support Organization Database. Crit Care Med (2017) 2.67
Is worsening renal function an ominous prognostic sign in patients with acute heart failure? The role of congestion and its interaction with renal function. Circ Heart Fail (2011) 2.28
Worsening renal function in patients hospitalised for acute heart failure: clinical implications and prognostic significance. Eur J Heart Fail (2008) 2.11
Role of aliskiren on arterial stiffness and endothelial function in patients with primary hypertension. J Clin Hypertens (Greenwich) (2014) 2.02
Prognostic effect of inappropriately high left ventricular mass in asymptomatic severe aortic stenosis. Heart (2010) 1.80
n-3 polyunsaturated fatty acids in the prevention of atrial fibrillation recurrences after electrical cardioversion: a prospective, randomized study. Circulation (2011) 1.71
Marked improvement in left ventricular ejection fraction during long-term beta-blockade in patients with chronic heart failure: clinical correlates and prognostic significance. Am Heart J (2003) 1.67
The role of n-3 PUFAs in preventing the arrhythmic risk in patients with idiopathic dilated cardiomyopathy. Cardiovasc Drugs Ther (2008) 1.63
Beta-blocker therapy influences the hemodynamic response to inotropic agents in patients with heart failure: a randomized comparison of dobutamine and enoximone before and after chronic treatment with metoprolol or carvedilol. J Am Coll Cardiol (2002) 1.49
High sensitivity C-reactive protein: a predictor for recurrence of atrial fibrillation after successful cardioversion. Intern Emerg Med (2009) 1.44
Usefulness of cardiac calcification on two-dimensional echocardiography for distinguishing ischaemic from nonischaemic dilated cardiomyopathy: a preliminary report. J Cardiovasc Med (Hagerstown) (2006) 1.43
Acute myocardial infarction in a young woman with antiphospholipid syndrome and occasional cocaine abuse. Int J Cardiol (2005) 1.40
Out of the guidelines: should an intracardiac defibrillator be implanted in patients with recurrent early ventricular fibrillation due to recurrent acute myocardial infarction? J Cardiovasc Med (Hagerstown) (2007) 1.38
[Plasma brain natriuretic peptide levels in the diagnostic and prognostic assessment of patients with heart failure. Pros]. Ital Heart J (2003) 1.38
Effects of n-3 polyunsaturated fatty acids on left ventricular function and functional capacity in patients with dilated cardiomyopathy. J Am Coll Cardiol (2011) 1.34
Beta-blocker treatment of patients with diastolic heart failure and arterial hypertension. A prospective, randomized, comparison of the long-term effects of atenolol vs. nebivolol. Eur J Heart Fail (2003) 1.25
Different signaling pathways induce apoptosis in endothelial cells and cardiac myocytes during ischemia/reperfusion injury. Circ Res (2002) 1.18
The role of the kidney in heart failure. Eur Heart J (2012) 1.16
Effects of the long-term administration of nebivolol on the clinical symptoms, exercise capacity, and left ventricular function of patients with diastolic dysfunction: results of the ELANDD study. Eur J Heart Fail (2011) 1.16
Serum levels of carbohydrate antigen 125 in patients with chronic heart failure: relation to clinical severity, hemodynamic and Doppler echocardiographic abnormalities, and short-term prognosis. J Am Coll Cardiol (2003) 1.13
The role of plasma biomarkers in acute heart failure. Serial changes and independent prognostic value of NT-proBNP and cardiac troponin-T. Eur J Heart Fail (2007) 1.08
The 6 minute walking test in chronic heart failure: indications, interpretation and limitations from a review of the literature. Eur J Heart Fail (2004) 1.05
Total arterial myocardial revascularization with composite grafts improves results of coronary surgery in elderly: a prospective randomized comparison with conventional coronary artery bypass surgery. Circulation (2003) 1.05
Percutaneous coronary angioplasty in a patient with anomalous single coronary artery arising from the right sinus of Valsalva. Int J Cardiol (2006) 1.05
Postdischarge assessment after a heart failure hospitalization: the next step forward. Circulation (2010) 1.00
How often we need to measure brain natriuretic peptide (BNP) blood levels in patients admitted to the hospital for acute severe heart failure? Role of serial measurements to improve short-term prognostic stratification. Int J Cardiol (2009) 0.97
Mitral valve repair or replacement for ischemic mitral regurgitation? The Italian Study on the Treatment of Ischemic Mitral Regurgitation (ISTIMIR). J Thorac Cardiovasc Surg (2012) 0.97
Role of beta-adrenergic receptor gene polymorphisms in the long-term effects of beta-blockade with carvedilol in patients with chronic heart failure. Cardiovasc Drugs Ther (2010) 0.95
Urocortin promotes hemodynamic and bioenergetic recovery and improves cell survival in the isolated rat heart exposed to ischemia/reperfusion. J Am Coll Cardiol (2002) 0.95
Longitudinal strain predicts left ventricular mass regression after aortic valve replacement for severe aortic stenosis and preserved left ventricular function. Heart Vessels (2012) 0.94
Off-pump coronary artery bypass surgery technique for total arterial myocardial revascularization: a prospective randomized study. Ann Thorac Surg (2003) 0.91
Absence of inferior vena cava as a rare cause of deep venous thrombosis complicated by liver and lung embolism. Int J Cardiol (2003) 0.90
Lack of association of coeliac disease with idiopathic and ischaemic dilated cardiomyopathies. Scand J Clin Lab Invest (2008) 0.90
Nebivolol: haemodynamic effects and clinical significance of combined beta-blockade and nitric oxide release. Drugs (2010) 0.90
Effect of spironolactone on left ventricular ejection fraction and volumes in patients with class I or II heart failure. Am J Cardiol (2010) 0.90
Role of beta1- and alpha2c-adrenergic receptor polymorphisms and their combination in heart failure: a case-control study. Eur J Heart Fail (2005) 0.89
Left internal thoracic artery-radial artery composite grafts as the technique of choice for myocardial revascularization in elderly patients: a prospective randomized evaluation. J Thorac Cardiovasc Surg (2004) 0.89
Homocysteine and heart failure: an overview. Recent Pat Cardiovasc Drug Discov (2009) 0.88
The 6-min walking test early after cardiac surgery. Reference values and the effects of rehabilitation programme. Eur J Cardiothorac Surg (2007) 0.88
How should we measure left atrium size and function? J Clin Ultrasound (2012) 0.87
Impact of preoperative anterior leaflet tethering on the recurrence of ischemic mitral regurgitation and the lack of left ventricular reverse remodeling after restrictive annuloplasty. J Am Soc Echocardiogr (2011) 0.87
Acute heart failure: multiple clinical profiles and mechanisms require tailored therapy. Int J Cardiol (2010) 0.87
Should beta-blocker therapy be reduced or withdrawn after an episode of decompensated heart failure? Results from COMET. Eur J Heart Fail (2007) 0.86
Cardiovascular and noncardiovascular comorbidities in patients with chronic heart failure. J Cardiovasc Med (Hagerstown) (2011) 0.86
Non-obstructive membranes of the left atrial appendage. Cardiovasc J Afr (2012) 0.85
The pathophysiology of acute heart failure--it is a lot about fluid accumulation. Am Heart J (2007) 0.85
Dynamic mild subaortic left ventricular obstruction caused by an accessory mitral valve attached to the anterior mitral valve in a young pregnant woman. Eur J Echocardiogr (2008) 0.84
Human fibrinogen/thrombin-coated collagen patch to control intraoperative severe pulmonary hemorrhage and air leakage after correction of a ruptured thoracic aortic aneurysm. Ann Thorac Surg (2011) 0.84
Pulmonary embolism complicated by impending paradoxical embolism - a case report and a review of literature. Kardiol Pol (2010) 0.84
Long-term prognostic value of the right ventricular myocardial performance index compared to other indexes of right ventricular function in patients with moderate chronic heart failure. Echocardiography (2012) 0.84
Extraction of a coronary sinus lead: always so easy? J Cardiovasc Med (Hagerstown) (2017) 0.83
Long-term prognosis of medically treated patients with functional mitral regurgitation and left ventricular dysfunction. Eur J Heart Fail (2009) 0.83
Early regression of left ventricular mass associated with diastolic improvement after transcatheter aortic valve implantation. J Am Soc Echocardiogr (2012) 0.83
Can we prevent or treat renal dysfunction in acute heart failure? Heart Fail Rev (2012) 0.83
N-3 PUFA increase bioavailability and function of endothelial progenitor cells. Food Funct (2014) 0.83
n-3 PUFAs and cardiovascular disease prevention. Future Cardiol (2010) 0.82
A difficult diagnosis: right unilateral cardiogenic pulmonary edema. Usefulness of biochemical markers of heart failure for the correct diagnosis. Ital Heart J (2005) 0.82
Effect of the long-term administration of nebivolol on clinical symptoms, exercise capacity and left ventricular function in patients with heart failure and preserved left ventricular ejection fraction: background, aims and design of the ELANDD study. Clin Res Cardiol (2009) 0.82
Psoriasis and cardiovascular diseases. Acta Cardiol (2010) 0.82
Diagnosis of cor triatriatum sinister in patient with pulmonary edema and severe pulmonary arterial hypertension: assessment by three-dimensional transesophageal echocardiography. Echocardiography (2011) 0.81
Right giant atrial thrombosis and pulmonary embolism complicating pacemaker leads. BMJ Case Rep (2013) 0.81
Serum levels of different tumour markers in patients with chronic heart failure. Eur J Heart Fail (2005) 0.81
Renal dysfunction in acute heart failure: epidemiology, mechanisms and assessment. Heart Fail Rev (2012) 0.81
Long-term prognostic value of CA 125 serum levels in mild to moderate heart failure patients. J Card Fail (2011) 0.81
Effects of spironolactone on long-term mortality and morbidity in patients with heart failure and mild or no symptoms. Am J Med Sci (2014) 0.81
Influence of type 2 diabetes on functional and structural properties of coronary artery bypass conduits. Diabetes (2003) 0.80
Treatment of heart failure in the elderly: never say it's too late. Eur Heart J (2009) 0.80
The effect of aldosterone-antagonist therapy on aortic elastic properties in patients with nonischemic dilated cardiomyopathy. J Cardiovasc Med (Hagerstown) (2015) 0.80
Troponin T levels in patients with acute heart failure: clinical and prognostic significance of their detection and release during hospitalisation. Clin Res Cardiol (2012) 0.80
QT prolongation: a case of arsenical pericardial and pleural effusion. Cardiovasc Toxicol (2007) 0.80
A focus on antiarrhythmic properties of ranolazine. J Cardiovasc Pharmacol Ther (2012) 0.79
Out-of-hospital cardiac arrest caused by transient left ventricular apical ballooning syndrome. Int J Cardiol (2007) 0.79
CA 125 tumoral marker plasma levels relate to systolic and diastolic ventricular function and to the clinical status of patients with chronic heart failure. Echocardiography (2008) 0.79
Effects of ranolazine on cardiovascular system. Recent Pat Cardiovasc Drug Discov (2011) 0.79
Multiorgan paradoxical embolism consequent to acute pulmonary thromboembolism with patent foramen ovale: a case report. Cases J (2009) 0.79
A scombroid poisoning causing a life-threatening acute pulmonary edema and coronary syndrome in a young healthy patient. Cardiovasc Toxicol (2011) 0.79
Cardiological features in idiopathic inflammatory myopathies. J Cardiovasc Med (Hagerstown) (2010) 0.79